Priser
Platform
Blog
Om os
Download
Athens Medical Center
Athens Medical Center
Xetra
0

Om

Athens Medical S.A. is a prominent entity within the healthcare sector, primarily focused on providing comprehensive medical services in Greece. As a leading healthcare provider, the company operates an expansive network of private hospitals and various medical centers, offering specialized services across multiple disciplines including cardiology, orthopedics, and neurology, among others. Up-to-date medical technology and facilities enhance the care provided at Athens Medical S.A., ensuring high standards of medical practices. It plays a vital role in the Greek healthcare system, catering to both domestic and international patients. Athens Medical S.A. is significant in the healthcare market in Greece not only for its quality care but also for its contribution to medical tourism, attracting patients from around the world seeking specialized treatments. Its commitment to excellence and innovation in medical care underscores its substantial influence and respected reputation within and beyond the Greek financial markets.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ATHENS MEDICAL CENTER MED ENDAVU: Køb Athens Medical Center ($ACS1) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Athens Medical Center, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerACS1
Land
Grækenland
Antal medarbejdere3.342
Hjemmesideiatriko.gr
SektorSundhed
IndustriMedicinske plejefaciliteter

Udbytter

0,02EUR
'24
Ex-udbytte-dato22. jul. 2024
Udbytteafkast0%